We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Pulmonary Medicine

Annals of Medicine

In the Pulmonary Medicine section of Annals of Medicine we consider for publication the latest advances in:

Alpha-1 Antitrypsin Deficiency Asthma Chronic Obstructive Pulmonary Disease (COPD) Cystic Fibrosis
Emphysema Infectious Diseases Interstitial Lung Disease (ILD) Lung Cancer
Lung Physiopathology Respiratory Failure Sleep Apnea


In addition, this section focuses on innovation that fosters discussion to push the boundaries of knowledge in all areas covered by this discipline.

Annals of Medicine

Q1 Rank

Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840

MEDLINE® Indexed

CiteScore 5.70

Meet the Section Editor

Laura Pini, MD, Professor of Respiratory Medicine, Department of Clinical and Experimental Sciences, University Hospital of Brescia, Italy

Professor Pini completed her Post-Doc at the Meakins Christie Laboratory, McGill University, Canada in 2005 where her research primarily focused on airway remodeling. Pini's research interests include lung pathophysiology, airway remodeling, severeal asthma and alpha-1 antitrypsin deficiency. Pini has contributed to several national and international pharmacological studies and published more than 100 peer-reviewed articles. Professor Pini is currently an active member of the European Respiratory Society, the European Alpha-1 antitrypsin deficiency Award (e-ALTA) Network, the Severe Asthma Network in Ital (SANI) and the Severe Heterogenous Asthma Research (SHARP) Clinical Research Collaboration. Pini also lectures and supervises medical residents enrolled in the University's Respiratory Medicine Program.

Why is Annals of Medicine the Best Publication for Your Research?

Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;

Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;

Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;

Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.

Read the Journal          Article Alerts          Submit Now